ARS Pharmaceuticals, Inc. SPRY Market capitalization

Market capitalization at other companies

Aquestive Therapeutics, Inc.AQST

$506.49M+76.6%

Amneal Pharmaceuticals, Inc.AMRX

$5.53B+117%

ViatrisVTRS

$18.49B+76.1%

AMP

Amphastar PharmaceuticalsAMPH

$889.8M-23.2%

Neuropace, Inc.NPCE

$442.72M+10.6%

Eton Pharmaceuticals, Inc.ETON

$673.38M+93.4%

FAQ

What is ARS Pharmaceuticals, Inc.'s market capitalization?

ARS Pharmaceuticals, Inc. (SPRY) reported market capitalization of $797.36M in Q1 2026.

How has ARS Pharmaceuticals, Inc.'s market capitalization changed year-over-year?

ARS Pharmaceuticals, Inc.'s market capitalization decreased by 35.4% year-over-year, from $1.23B to $797.36M.

What is the long-term trend for ARS Pharmaceuticals, Inc.'s market capitalization?

Over 5 years (2020 to 2025), ARS Pharmaceuticals, Inc.'s market capitalization has grown at a -6.5% compound annual growth rate (CAGR), from $1.61B to $1.15B.

What does market capitalization mean?

The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.